A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
Clinical trial NCT06309992 · COMPLETED
Trial details
- NCT number
- NCT06309992
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2025-10-09
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.